Evidence map›Paper›PMID 24035328›Full record

ArticleInternational journal of radiation oncology, biology, physics2013

Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.

Klaudia U Hunter, Laura L Fernandes, Karen A Vineberg, Daniel McShan, Alan E Antonuk, Craig Cornwall, Mary Feng, Mathew J Schipper, James M Balter, Avraham Eisbruch

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01661062 (A Pilot Study of Tumor and Critical Normal Tissue Motion in Head and Neck Cancer Using Cone Beam CT), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01661062 nacompletednot on this map

A Pilot Study of Tumor and Critical Normal Tissue Motion in Head and Neck Cancer Using Cone Beam CT

TypeinterventionalSponsorUniversity of Michigan Rogel Cancer CenterRan2009 to 2016Enrolled23ConditionsHead and Neck CancerArmsCone Beam Computed Tomography (CT) Scan
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer.Journal of personalized medicine · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Adjuvant radiotherapy in malignant tumors of parotid. Experience of the Navarra Hospital Complex.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2021
    Article
  15. Predictive dose accumulation for HN adaptive radiotherapy.Physics in medicine and biology · 2020
    Article
  16. Article
  17. Adaptive radiotherapy for head and neck cancer.Cancers of the head & neck · 2020
    Review
  18. Article
  19. Future of Radiotherapy in Nasopharyngeal Carcinoma.The British journal of radiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Klaudia U HunterDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Laura L Fernandes
Karen A Vineberg
Daniel McShan
Alan E Antonuk
Craig Cornwall
Mary Feng
Mathew J Schipper
James M Balter
Avraham Eisbruch
University of Michigan–Ann Arbor · US

Funding

TREATMENT VERIFICATION AND TREATMENT PLAN REFINEMENTP01CA059827 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KESSLER, MARC LEWIS, LAWRENCE, THEODORE S · 1993 to 2018
$37.9M
NCI NIH HHS P01 CA059827NCI NIH HHS P01CA59827
6 · The paper itself

Abstract

purposeDoses actually delivered to the parotid glands during radiation therapy often exceed planned doses. We hypothesized that the delivered doses correlate better with parotid salivary output than the planned doses, used in all previous studies, and that determining these correlations will help make decisions regarding adaptive radiation therapy (ART) aimed at reducing the delivered doses. METHODS AND MATERIALS: In this prospective study, oropharyngeal cancer patients treated definitively with chemoirradiation underwent daily cone-beam computed tomography (CBCT) with clinical setup alignment based on the C2 posterior edge. Parotid glands in the CBCTs were aligned by deformable registration to calculate cumulative delivered doses. Stimulated salivary flow rates were measured separately from each parotid gland pretherapy and periodically posttherapy.

resultsThirty-six parotid glands of 18 patients were analyzed. Average mean planned doses was 32 Gy, and differences from planned to delivered mean gland doses were -4.9 to +8.4 Gy, median difference +2.2 Gy in glands in which delivered doses increased relative to planned. Both planned and delivered mean doses were significantly correlated with posttreatment salivary outputs at almost all posttherapy time points, without statistically significant differences in the correlations. Large dispersions (on average, SD 3.6 Gy) characterized the dose-effect relationships for both. The differences between the cumulative delivered doses and planned doses were evident at first fraction (r=.92, P<.0001) because of complex setup deviations (eg, rotations and neck articulations), uncorrected by the translational clinical alignments.

conclusionsAfter daily translational setup corrections, differences between planned and delivered doses in most glands were small relative to the SDs of the dose-saliva data, suggesting that ART is not likely to gain measurable salivary output improvement in most cases. These differences were observed at first treatment, indicating potential benefit for more complex setup corrections or adaptive interventions in the minority of patients with large deviations detected early by CBCT.

Indexed as

AgedAntineoplastic Combined Chemotherapy ProtocolsCarboplatinChemoradiotherapyCone-Beam Computed TomographyDose-Response Relationship, RadiationFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedOrgans at RiskOropharyngeal NeoplasmsPaclitaxelParotid GlandProspective StudiesCarboplatinPaclitaxel

Identifiers

PMID24035328
PMCPMC3805710
OpenAlexW1995373556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.